Repository logo
Log In
  1. Home
  2. Unibas
  3. Publications
  4. Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis
 
  • Details

Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis

Date Issued
2019-01-01
Author(s)
Gygli, Sebastian M.  
Keller, Peter M.
Ballif, Marie
Blöchliger, Nicolas
Hömke, Rico
Reinhard, Miriam  
Loiseau, Chloé  
Ritter, Claudia
Sander, Peter
Borrell, Sonia  
Collantes Loo, Jimena
Avihingsanon, Anchalee
Gnokoro, Joachim
Yotebieng, Marcel
Egger, Matthias
Gagneux, Sebastien  
Böttger, Erik C.
DOI
10.1128/aac.02175-18
Abstract
Whole-genome sequencing allows rapid detection of drug-resistant; Mycobacterium tuberculosis; isolates. However, the availability of high-quality data linking quantitative phenotypic drug susceptibility testing (DST) and genomic data have thus far been limited. We determined drug resistance profiles of 176 genetically diverse clinical; M. tuberculosis; isolates from the Democratic Republic of the Congo, Ivory Coast, Peru, Thailand, and Switzerland by quantitative phenotypic DST for 11 antituberculous drugs using the BD Bactec MGIT 960 system and 7H10 agar dilution to generate a cross-validated phenotypic DST readout. We compared DST results with predicted drug resistance profiles inferred by whole-genome sequencing. Classification of strains by the two phenotypic DST methods into resistotype/wild-type populations was concordant in 73 to 99% of cases, depending on the drug. Our data suggest that the established critical concentration (5 mg/liter) for ethambutol resistance (MGIT 960 system) is too high and misclassifies strains as susceptible, unlike 7H10 agar dilution. Increased minimal inhibitory concentrations were explained by mutations identified by whole-genome sequencing. Using whole-genome sequences, we were able to predict quantitative drug resistance levels for the majority of drug resistance mutations. Predicting quantitative levels of drug resistance by whole-genome sequencing was partially limited due to incompletely understood drug resistance mechanisms. The overall sensitivity and specificity of whole-genome-based DST were 86.8% and 94.5%, respectively. Despite some limitations, whole-genome sequencing has the potential to infer resistance profiles without the need for time-consuming phenotypic methods.
File(s)
Loading...
Thumbnail Image
Name

20190418090432_5cb82180ad9e9.pdf

Size

1.83 MB

Format

Adobe PDF

Checksum

(MD5):ca2ec083553a9b5b815a0d9d4fa4023b

University of Basel

edoc
Open Access Repository University of Basel

  • About edoc
  • About Open Access at the University of Basel
  • edoc Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement